Special feature
The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients

https://doi.org/10.1016/j.healun.2010.05.034Get rights and content

Institutional Affiliations

Chair

Costanzo MR: Midwest Heart Foundation, Lombard Illinois, USA

Task Force 1

Dipchand A: Hospital for Sick Children, Toronto Ontario, Canada; Starling R: Cleveland Clinic Foundation, Cleveland, Ohio, USA; Anderson A: University of Chicago, Chicago, Illinois, USA; Chan M: University of Alberta, Edmonton, Alberta, Canada; Desai S: Inova Fairfax Hospital, Fairfax, Virginia, USA; Fedson S: University of Chicago, Chicago, Illinois, USA; Fisher P: Ochsner Clinic, New Orleans, Louisiana, USA; Gonzales-Stawinski G: Cleveland Clinic Foundation, Cleveland, Ohio, USA; Martinelli L: Ospedale Niguarda, Milano, Italy; McGiffin D: University of Alabama, Birmingham, Alabama, USA; Parisi F: Ospedale Pediatrico Bambino Gesù, Rome, Italy; Smith J: Freeman Hospital, Newcastle upon Tyne, UK

Task Force 2

Taylor D: Cleveland Clinic Foundation, Cleveland, Ohio, USA; Meiser B: University of Munich/Grosshaden, Munich, Germany; Baran D: Newark Beth Israel Medical Center, Newark, New Jersey, USA; Carboni M: Duke University Medical Center, Durham, North Carolina, USA; Dengler T: University of Hidelberg, Heidelberg, Germany; Feldman D: Minneapolis Heart Institute, Minneapolis, Minnesota, USA; Frigerio M: Ospedale Niguarda, Milano, Italy; Kfoury A: Intermountain Medical Center, Murray, Utah, USA; Kim D: University of Alberta, Edmonton, Alberta, Canada; Kobashigawa J: Cedar-Sinai Heart Institute, Los Angeles, California, USA; Shullo M: University of Pittsburgh, Pittsburgh, Pennsylvania, USA; Stehlik J: University of Utah, Salt Lake City, Utah, USA; Teuteberg J: University of Pittsburgh, Pittsburgh, Pennsylvania, USA; Uber P: University of Maryland, Baltimore, Maryland, USA; Zuckermann A: University of Vienna, Vienna, Austria.

Task Force 3

Hunt S: Stanford University, Palo Alto, California, USA; Burch M: Great Ormond Street Hospital, London, UK; Bhat G: Advocate Christ Medical Center, Oak Lawn, Illinois, USA; Canter C: St. Louis Children Hospital, St. Louis, Missouri, USA; Chinnock R: Loma Linda University Children's Hospital, Loma Linda, California, USA; Crespo-Leiro M: Hospital Universitario A Coruña, La Coruña, Spain; Delgado R: Texas Heart Institute, Houston, Texas, USA; Dobbels F: Katholieke Universiteit Leuven, Leuven, Belgium; Grady K: Northwestern University, Chicago, Illlinois, USA; Kao W: University of Wisconsin, Madison Wisconsin, USA; Lamour J: Montefiore Medical Center, New York, New York, USA; Parry G: Freeman Hospital, Newcastle upon Tyne, UK; Patel J: Cedar-Sinai Heart Institute, Los Angeles, California, USA; Pini D: Istituto Clinico Humanitas, Rozzano, Italy; Pinney S: Mount Sinai Medical Center, New York, New York, USA; Towbin J: Cincinnati Children's Hospital, Cincinnati, Ohio, USA; Wolfel G: University of Colorado, Denver, Colorado, USA

Independent Reviewers

Delgado D: University of Toronto, Toronto, Ontario, Canada; Eisen H: Drexler University College of Medicine, Philadelphia, Pennsylvania, USA; Goldberg L: University of Pennsylvania, Philadelphia, Pennsylvania, USA; Hosenpud J: Mayo Clinic, Jacksonville, Florida, USA; Johnson M: University of Wisconsin, Madison, Wisconsin, USA; Keogh A: St Vincent Hospital, Sidney, New South Wales, Australia; Lewis C: Papworth Hospital Cambridge, UK; O'Connell J: St. Joseph Hospital, Atlanta, Georgia, USA; Rogers J: Duke University Medical Center, Durham, North Carolina, USA; Ross H: University of Toronto, Toronto, Ontario, Canada; Russell S: Johns Hopkins Hospital, Baltimore, Maryland, USA; Vanhaecke J: University Hospital Gasthuisberg, Leuven, Belgium.

Section snippets

Task Force 1: Peri-operative Care of the Heart Transplant Recipient

Chair: Maria Rosa Costanzo, MD; Co-Chairs: Anne Dipchand, MD; Randall Starling, MD

Contributing Writers: Allen Anderson, MD; Michael Chan, MD; Shashank Desai, MD; Savitri Fedson, MD; Patrick Fisher, MD; Gonzalo Gonzales-Stawinski, MD; Luigi Martinelli, MD; David McGiffin, MD; Jon Smith, MD

Task Force 2: Immunosuppression and Rejection

Chair: David Taylor, MD; Co-Chairs: Bruno Meiser, MD; Steven Webber, MD

Contributing Writers: David Baran, MD; Michael Carboni, MD; Thomas Dengler, MD; David Feldman, MD; Maria Frigerio, MD; Abdallah Kfoury, MD; Daniel Kim, MD; Jon Kobashigawa, MD; Michael Shullo, PhD; Josef Stehlik, MD; Jeffrey Teuteberg, MD; Patricia Uber, PharmD; Andreas Zuckermann, MD

Task Force 3: Long-term Care of Heart Transplant Recipients

Chair: Sharon Hunt, MD; Co-Chair: Michael Burch

Contributing Writers: Geetha Bhat, MD; Charles Canter, MD; Richard Chinnock, MD; Marisa Crespo-Leiro, MD; Reynolds Delgado, MD; Fabienne Dobbels, PhD; Kathleen Grady, PhD; Walter Kao, MD; Jaqueline Lamour, MD; Gareth Parry, MD; Jignesh Patel, MD; Daniela Pini, MD; Jeffrey Towbin, MD; Gene Wolfel, MD

References (396)

  • E.B. Stinson et al.

    Hemodynamic observations in the early period after human heart transplantation

    J Thorac Cardiovasc Surg

    (1975)
  • S. Zieroth et al.

    Permanent pacing after cardiac transplantation in the era of extended donors

    J Heart Lung Transplant

    (2006)
  • M. Ibrahim et al.

    Management of acute severe perioperative failure of cardiac allografts: a single-centre experience with a review of the literature

    Can J Cardiol

    (2007)
  • G. Santise et al.

    Levitronix as a short-term salvage treatment for primary graft failure after heart transplantation

    J Heart Lung Transplant

    (2006)
  • J. Huang et al.

    Risk factors for primary graft failure after pediatric cardiac transplantation: importance of recipient and donor characteristics

    J Heart Lung Transplant

    (2004)
  • B. Stobierska-Dzierzek et al.

    The evolving management of acute right-sided heart failure in cardiac transplant recipients

    J Am Coll Cardiol

    (2001)
  • V. Jeevanandam et al.

    Donor tricuspid annuloplasty during orthotopic heart transplantation: long-term results of a prospective controlled study

    Ann Thorac Surg

    (2006)
  • R.C. Wong et al.

    Tricuspid regurgitation after cardiac transplantation: an old problem revisited

    J Heart Lung Transplant

    (2008)
  • P.J. Hauptman et al.

    Pericardial effusions after cardiac transplantation

    J Am Coll Cardiol

    (1994)
  • J.A. Quin et al.

    Predictors of pericardial effusion after orthotopic heart transplantation

    J Thorac Cardiovasc Surg

    (2002)
  • R.G. Leyh et al.

    Methylene blue: the drug of choice for catecholamine-refractory vasoplegia after cardiopulmonary bypass?

    J Thorac Cardiovasc Surg

    (2003)
  • D.L. Morales et al.

    A double-blind randomized trial: prophylactic vasopressin reduces hypotension after cardiopulmonary bypass

    Ann Thorac Surg

    (2003)
  • L.S. De Santo et al.

    Role of sildenafil in acute posttransplant right ventricular dysfunction: successful experience in 13 consecutive patients

    Transplant Proc

    (2008)
  • O.E. Arafa et al.

    Intraaortic balloon pumping for predominantly right ventricular failure after heart transplantation

    Ann Thorac Surg

    (2000)
  • J.M. Chen et al.

    Experience with right ventricular assist devices for perioperative right-sided circulatory failure

    Ann Thorac Surg

    (1996)
  • A. Costard-Jackle et al.

    Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group

    J Am Coll Cardiol

    (1992)
  • J.M. Chen et al.

    Reevaluating the significance of pulmonary hypertension before cardiac transplantation: determination of optimal thresholds and quantification of the effect of reversibility on perioperative mortality

    J Thorac Cardiovasc Surg

    (1997)
  • E.C. Stecker et al.

    Arrhythmias after orthotopic heart transplantation

    J Card Fail

    (2005)
  • S.Z. Gao et al.

    Characteristics of serial electrocardiograms in heart transplant recipients

    Am Heart J

    (1991)
  • B.B. Pavri et al.

    Prevalence and prognostic significance of atrial arrhythmias after orthotopic cardiac transplantation

    J Am Coll Cardiol

    (1995)
  • M. Vaseghi et al.

    Supraventricular tachycardia after orthotopic cardiac transplantation

    J Am Coll Cardiol

    (2008)
  • J.R. Rubel et al.

    Renal insufficiency and end-stage renal disease in the heart transplant population

    J Heart Lung Transplant

    (2004)
  • M.R. Costanzo et al.

    Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure

    J Am Coll Cardiol

    (2007)
  • J.M. Boyle et al.

    Risks and outcomes of acute kidney injury requiring dialysis after cardiac transplantation

    Am J Kidney Dis

    (2006)
  • A. Anselm et al.

    Prolonged basiliximab use as an alternative to calcineurin inhibition to allow renal recovery late after heart transplantation

    J Heart Lung Transplant

    (2008)
  • A.P. Furnary et al.

    Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting

    J Thorac Cardiovasc Surg

    (2003)
  • J.A. Hawkins et al.

    Class I and class II anti-HLA antibodies after implantation of cryopreserved allograft material in pediatric patients

    J Thorac Cardiovasc Surg

    (2000)
  • F.D. Pagani et al.

    Development of anti-major histocompatibility complex class I or II antibodies following left ventricular assist device implantation: effects on subsequent allograft rejection and survival

    J Heart Lung Transplant

    (2001)
  • A.S. Betkowski et al.

    Panel-reactive antibody screening practices prior to heart transplantation

    J Heart Lung Transplant

    (2002)
  • J. Kobashigawa et al.

    Report from a consensus conference on the sensitized patient awaiting heart transplantation

    J Heart Lung Transplant

    (2009)
  • H.M. Gebel et al.

    Pre-transplant assessment of donor-reactive, HLA-specific antibodies in renal transplantation: contraindication vs. risk

    Am J Transplant

    (2003)
  • S.K. Takemoto et al.

    National conference to assess antibody-mediated rejection in solid organ transplantation

    Am J Transplant

    (2004)
  • B.A. Pisani et al.

    Plasmapheresis with intravenous immunoglobulin G is effective in patients with elevated panel reactive antibody prior to cardiac transplantation

    J Heart Lung Transplant

    (1999)
  • D.B. Holt et al.

    Mortality and morbidity in pre-sensitized pediatric heart transplant recipients with a positive donor crossmatch utilizing peri-operative plasmapheresis and cytolytic therapy

    J Heart Lung Transplant

    (2007)
  • S.L. Roche et al.

    Multicenter experience of ABO-incompatible pediatric cardiac transplantation

    Am J Transplant

    (2008)
  • L.J. West et al.

    Impact on outcomes after listing and transplantation, of a strategy to accept ABO blood group-incompatible donor hearts for neonates and infants

    J Thorac Cardiovasc Surg

    (2006)
  • J. Hirsh

    Reversal of the anticoagulant effects of warfarin by vitamin K1

    Chest

    (1998)
  • S. Schulman et al.

    Anticoagulants and their reversal

    Transfus Med Rev

    (2007)
  • S. Selleng et al.

    Management of anticoagulation in patients with subacute heparin-induced thrombocytopenia scheduled for heart transplantation

    Blood

    (2008)
  • S.V. Pamboukian et al.

    Management strategies for heparin-induced thrombocytopenia in heart-transplant candidates: case report and review of the literature

    J Heart Lung Transplant

    (2000)
  • Cited by (1275)

    View all citing articles on Scopus

    Reprint requests: Amanda W. Rowe, International Society for Heart and Lung Transplantation, 14673 Midway Road, Suite 200, Addison, TX 75001. Telephone: 804-873-2541. Fax: 817-912-1237.

    E-mail address: [email protected]; [email protected]

    View full text